Amar P. Singh
Nessuna posizione attualmente
Profilo
Amar P.
Singh formerly worked at Specialty Care, Inc., as Executive Director-Oncology Marketing in 2003, Roche Laboratories, Inc., as Executive Director-Oncology Marketing from 2000 to 2003, Spectrum Pharmaceuticals, Inc., as Chief Commercial Officer from 2008 to 2009, American Pharmaceutical Partners, Inc., as VP-Marketing & Sales Abraxis Oncology Division, Synta Pharmaceuticals Corp., as Chief Business Officer & Senior Vice President from 2011 to 2014, Novacea, Inc., as Chief Commercial Officer, Abraxis BioScience, Inc., as Vice President-Sales & Marketing from 2004 to 2007, Abraxis Oncology, as Vice President-Marketing & Sales from 2003 to 2006, and Sorrento Therapeutics, Inc., as Chief Business Officer & Executive Vice President in 2014.
Mr. Singh received his undergraduate degree from The University of North Carolina at Charlotte and Masters Business Admin degree from The Leonard N Stern School of Business.
Precedenti posizioni note di Amar P. Singh
| Società | Posizione | Fine |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 30/07/2014 |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 02/01/2014 |
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2009 |
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Corporate Officer/Principal | - |
Abraxis BioScience, Inc. /Old/
 Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Vendite & Marketing | 15/11/2007 |
Formazione di Amar P. Singh
| The University of North Carolina at Charlotte | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 7 |
|---|---|
Abraxis Oncology
 Abraxis Oncology Pharmaceuticals: MajorHealth Technology Abraxis Oncology is a biopharmaceutical company that specializes in discovering, developing, and delivering innovative medicines to help patients overcome serious diseases. Abraxis Oncology is based in Bridgewater, NJ. The private company's focus is on improving patient outcomes through the development of new treatments. | Health Technology |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Distribution Services |
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Synta Pharmaceuticals Corp. discovers, develops and commercializes pharmaceutical products. It focuses on the research, development and commercialization of oncology medicines that provides treatment to cancer patients. The company is also developing a proprietary platform for delivery of anti-cancer drugs directly to tumor cells, known as Hsp90-inhibitor drug conjugates. Synta Pharmaceuticals was founded by Safi R. Bahcall and Lan-Bo Chen in March 2000 and is headquartered in Lexington, MA. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Novacea, Inc.
Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA. | Health Technology |
American Pharmaceutical Partners, Inc.
 American Pharmaceutical Partners, Inc. Pharmaceuticals: MajorHealth Technology American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL. | Health Technology |
Specialty Care, Inc.
 Specialty Care, Inc. Hospital/Nursing ManagementHealth Services Specialty Care, Inc. provides retirement and nursing services. The private company is based in Vaughan, Canada. | Health Services |
- Borsa valori
- Insiders
- Amar P. Singh
